Hoosier Cancer Research Network (HCRN) will have an exhibitors booth at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting. Visit Booth #28115 to talk with our highly qualified staff about our 35 years of experience managing oncology/hematology multi-center clinical trials.

HCRN will host in-person meetings for the Breast Cancer, Gastrointestinal, Thoracic, Melanoma, and the Genitourinary Clinical Trial Working group during ASCO 2023. If you would like to schedule time with an HCRN staff member during ASCO please reach out to Randy Dillinger at rdillinger@hoosiercancer.org.

To request a calendar invitation with the location of the meeting, please contact Debbie Schlegel at dschlegel@hoosiercancer.org. Some meetings will have a virtual option for those who cannot attend in person.

Thoracic Clinical Trial Working Group: Saturday June 3, 2023 at 7:30 PM CT

Gastrointestinal Clinical Trial Working Group: Sunday June 4, 2023 at 7 AM CT

Genitourinary Clinical Trial Working Group: Sunday June 4, 2023 at 7 AM CT

Melanoma Clinical Trial Working Group: Sunday June 4, 2023 at 7:30 PM CT

Through HCRN’s Clinical Trial Working Groups, investigators receive scientific input from their peers to ensure protocols are well designed and to gauge interest among potential study sites. HCRN facilitates regular virtual meetings to keep all members of the study team apprised of a study’s progress and to address any concerns or challenges that arise.

About Hoosier Cancer Research Network

Hoosier Cancer Research Network conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has conducted more than 230 trials in a variety of cancer types and supportive care, resulting in more than 350 publications. More than 9,000 subjects have participated in Hoosier Cancer Research Network clinical trials.